MELISSA AMBROSIO: Open Payments
NPI 1871837872 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 37 payments from 11 companies in 2025. Trend: 2023 $315 · 2024 $504 · 2025 $921
Food & beverage: $841Education: $80
| Company | Payments | Amount |
|---|---|---|
| Davol Inc. | 2 | $149 |
| Janssen Biotech, Inc. | 7 | $137 |
| LEO Pharma Inc. | 6 | $134 |
| ABBVIE INC. | 5 | $120 |
| AtriCure, Inc. | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| Galderma Laboratories, L.P. | 4 | $78 |
| UCB, Inc. | 2 | $53 |
| Incyte Corporation | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: TREMFYA, Channel Drain, SKYRIZI, ADBRY, DUPIXENT, NEMLUVIO, SYNERGY ABLATION SYSTEM, Bimzelx.
Industry payments across CA — which companies pay providers there.
